 |
| Success Stories |
 |
|
|
|
|
|
|
| |
2005
CIS Pharma acquires co-marketing rights for Naturaceutical Delivery Corporation's Preservative Free Drug Delivery System. In co-operation with its partner CIS Pharma offers complete product development in the fields of ophthalmology, ENT, dermatology, cosmeceuticals and traditional cosmetics.
|
|
| |
2004
CIS Pharma licenses to Ophthalmopharma water soluble Cyclosporin A for the treatment of dry eye syndrome in pre-clinical stage.
|
|
| |
2003
Development of up-scalable, in-process controlled, continuous flow solid phase peptide syntheses including phase transfer catalysis for oxidation and cyclisation.
|
|
| |
2002
Rolf Schäfer and Amcis AG received the 2002 Entrepreneurial Award for small/mid-sized companies.
|
|
| |
1999
Development of a water soluble cyclosporine formulation, to be manufactured by Amcis AG.
|
|
| |
1998
Development of the first "in the eye" contact lens cleaner, licensed to and distributed by Alcon Laboratories under the name of Clens 100® (Europe) / Clerz Plus® (USA).
|
|
| |
1993
Development of a liquid enzyme based contact lens cleaner, licensed to and distributed by Alcon Laboratories under the name of Supraclens®.
|
|
| |
1993
Chiral synthesis of brinzolamide carbonic anhydrase inhibitor.
|
|
| |
1992-1985
Development and licensing of skin care products:
- ARCADIA®, marketed in Asia, specially formulated for Asian skin
- GLYCEL®, a cell regeneration therapy, promoted by heart surgeon Dr. Christian Barnard in the USA
- CONTABELLE®, marketed in Europe, skin care formula for contact lens wearers
|
|
| |
1990
Development and licensing of continuous flow solid phase peptide synthesis of calcitonin.
|
|
| |
1988
Development and licensing of coumarin and its transdermal drug delivery system.
|
|
| |
1987
Development of the first synthetic pilocarpine.
|
|
| |
1987
Development and licensing of terlipressin peptide with indication for acute oesophagus bleedings.
|
|
| |
1984
Research with heart transplant pioneer Dr. Christian Barnard on cell differentiation and immune response, development of anti-aging technology.
|
|
| |
1982
Development of a liposomal drug delivery system.
|
|
| |
1979
Development of homogeneous gazoline-water fuel systems for the preservation of natural resources.
|
|
| |
1978
Development of the first amphoteric group of symmetric imidazolin surfactants.
Formulation and licensing of personal hygiene products.
|
|
| |
1977
Development and licensing of a water soluble insecticide for IV injections for pets.
|
|
| |
1977
Development and licensing of Meglaten®, a cleaner for automated blood analysers.
|
|
| |
1952
Development of 60 speciality cleaners for the chemical treatment of metallic surfaces. The were used by NASA for the lunar module in the Apollo 12 program, by the NATO for fighter planes and for the decontamination of the nuclear-powered engine of the German vessel "Otto Hahn". All products are licensed to Hacoba AG. www.hacoba.ch
|
|
| |
1949
Development of alkylolamide-sulfates, the first group of biodegradable mild surfactants resulting in the formulation of a commercial product. It was the first laundry detergent in powder form produced by REI-Chemie in Western Germany.
|
|
| |
1947
Development of the first fully synthetic benzyl-penicillin.
|
|
| |
© 2003-2007 Chemisches Institut Schäfer AG. All rights reserved.
|
